CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat rare and serious conditions that include immunodeficiency and autoimmune diseases, hereditary and acquired bleeding disorders, hereditary angioedema, hereditary emphysema, and in transplantation and critical care.
Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in everything we do. We continue to introduce new innovations that address unmet medical needs or enhance current treatments. CSL Behring offers the broadest range of quality products in the protein biotherapeutics industry. Whether we are manufacturing and marketing safe and effective products or researching and developing innovative biotherapies, we are first and foremost focused on fulfilling our customers’ needs.